The Role of Tyrosine Phosphorylation in Regulation of Signal Transduction Pathways in Unicellular Eukaryotes

Total Page:16

File Type:pdf, Size:1020Kb

The Role of Tyrosine Phosphorylation in Regulation of Signal Transduction Pathways in Unicellular Eukaryotes Curr. Issues Mol. Biol. 8: 27–50. Online journal at www.cimb.org The Role of Tyrosine Phosphorylation in Regulation of Signal Transduction Pathways in Unicellular Eukaryotes Irina V. Schemarova transducer and activator of transcription) proteins located in the cytoplasm. This transmission is also provided by Sechenov Institute of Evolutionary Physiology and the SH2 domain contacts responsible for coupling of Biochemistry, Russian Academy of Sciences, St. phosphotyrosine-containing proteins (Darnell, 1997). Petersburg 194223, Russia The structural-functional organization of Ras-MAPK and STAT signaling pathways in vertebrate cells has Abstract been intensively studied for more than 20 years. By The review summarizes for the frst time the current the present time an extensive experimental material concepts of the role of tyrosine phosphorylation in has been accumulated, which allows judging about the regulation of signal transduction pathways in unicellular events in cells of the higher eukaryotes at each stage of eukaryotes. Evolutionary concepts are developed about transmission of proliferative signal. Much less is known the origin of protein tyrosine kinases (PTK)-signaling. about mechanisms of transmission of growth signals in cells of primitive eukaryotes. There are practically no data Introduction in the literature about the existence of their STAT and Ras- At the end of the last century, in mammalian cells a multi- MAPK pathways of the signal transmission; meanwhile, it cascade pathway was discovered to be responsible for is obvious that RTKs exist not only in mammals, but in transmission of proliferative signals into genome. The multicellular invertebrates, including the most primitive key role in the signal transmission through this pathway — sponges and coelenterates (Schartl, Barnekow, 1982; is played by processes of phosphorylation of protein Schartl et al., 1989; Kruse et al., 1997). tyrosine residues (Hunter, 1995; Marshall, 1995; Feig et Our analysis of experimental and literature data al., 1996; Mustelin et al., 2002). has shown that tyrosine phosphorylation also takes Ushiro and Cohen (1980) were the frst to establish place in cells of unicellular eukaryotes. The presence the important role of phosphorylation of tyrosine as a in eukaryotic microorganisms of tyrosine kinases and regulator of intracellular processes and to reveal changes proteins phosphorylated at tyrosine in processes of of tyrosine kinase activity of proteins in mammalian cells growth, cellular differentiation, and adaptive response in response to action of growth factors. Subsequently, the indicates a more ancient origin of mechanisms of PTK- change of the protein tyrosine kinase activity was shown signaling than this was believed earlier. to underlie the Ras-MAPK signaling pathway regulated This review focuses on the role of mammalian growth by Mitogen-Activated Protein (MAP) kinases (Hunter and factors, tyrosine kinases, and phosphotyrosine-containing Cooper, 1985). proteins in signaling in unicellular eukaryotes. Phosphorylation of tyrosine residues in proteins is catalyzed by retrovirus protein tyrosine kinases (PTKs), Effects of mammalian growth factors on unicellular their cellular homologues (Bishop, 1983) or by tyrosine organisms kinases associated with growth factor receptors (Yarden Due to the accepted concept that PTK-signaling takes and Ullrich, 1988; Broome and Hunter, 1996). These place only in cells of the higher eukaryotes, many aspects proteins were studied in detail and classifed in vertebrate of the problem of evolutionary origin of this signaling are animals (Hanks and Hunter, 1995). kept in the shade. Thus, for instance, nothing, in fact, is The classical scheme of transmission of the prolifera- known about evolution of mechanisms of activation of the tive signals through the pathway mediated by growth signal pathways dependent on tyrosine phosphorylation. factors (Ras-MAPK pathway) includes: (1) association of In this connection, it seems important to growth factor with receptor, (2) dimerization of receptor and consider pathways of signal transmission by tyrosine autophosphorylation of receptor tyrosine kinase (RTK), phosphorylation in unicellular eukaryotes, whose cells (3) module coupling of RTK with adaptor SH2 domain have no typical growth receptors and RTKs. proteins; activation of Ras, (4) phosphorylation and It would have been logical to suggest that unicellular activation of MAP kinases, (5) transmission of signal into eukaryotes deprived of typical receptors of mammalian genome. growth factors could not and should not respond to signals At the end of the last century, another pathway of initiated by mammalian growth factors. However, in reality, transmission of proliferative signals into genome, with this is not so. Studies performed for the last few years participation of growth factors and tyrosine kinases, was have shown that the mammalian growth factors (TGFA, discovered (Shuai et al., 1994). This is the monocascade EGF, FGF, HGF, etc.) can initiate proliferative effect not STAT pathway activated by receptors of growth factors only in mammalian cells, but also in unicellular animals. and cytokines. The essence of this transmission consists The stimulating effect of mammalian growth factors on in direct activation by tyrosine kinases of the STAT (signal proliferative growth of eukaryotic microorganisms was revealed for the frst time in the parasitic protozoa Giardia lamblia (Lujan et al, 1994). The mitogenic effect on For correspondence: [email protected] © Horizon Scientifc Press. Offprints from www.cimb.org 28 Schemarova growth of G. lamblia was produced by insulin-like factors and membrane-associated proteins that, in the authors’ IGF-I and IGF-II (Lujan et al, 1994). They were shown opinion (Gugssa et al., 2000), became involved in control to accelerate growth and L-cysteine incorporation in G. of growth and reproduction of T. musculi. lamblia trophozoites cultivated axenically in a serum- Platelet growth factor (PDGF), whose receptors free medium. The insulin-like factors act through the in mammals also have their own tyrosine kinase parasite membrane glycoprotein that has immunological activity, stimulated macromolecular synthesis in the characteristics similar to those of the mammalian IGF-I. ciliate Tetrahymena pyriformis (Andersen et al., 1984). In reaction of immunoprecipitation of lysate of G. lamblia Measurements of changes in the labeled uridine specifc trophozoites incubated with human recombinant IGF-II, activity in the UTP pool after PDGF treatment showed an with monoclonal antibody AIR3, proteins of a molecular initial increase lasting for about 40 min. Thereafter the mass of 70 kDa were found; one of them, as shown by RNA synthesis rate gradually decreased and became further studies using polyclonal antibody to the IGF- the same as in intact cells after 2 hr of incubation. PDGF I receptor, corresponded to the IGF-I receptor A-chain. also stimulated the labeled uridine incorporation in T. Protein of a molecular mass of 95 kDa that corresponded pyriformis. The increase begins shortly after addition of to the receptor IGF-I B-chain was discovered using this growth factor and levels off 2–3 h later. The data polyclonal antibody to phosphotyrosine. Based on the obtained by these authors (Andersen et al., 1984) rule obtained data, the authors suggested the existence in out a possibility of induction of changes in the nucleotide the membrane glycoproteins of G. lamblia trophozoites pool of precursors both of RNA and of DNA by PDGF in T. of internal tyrosine kinase activity and the capability for pyriformis. The authors suggested T. pyriformis to contain autophosphorylation. receptors on its surface for the growth factor. The promoter effect of IGF-I on cell growth was also Colony-stimulating growth factor (CSF) from revealed in cells of the parasitic protozoa Leishmania granulocytes stimulated proliferative response and mexicana (Gomes et al., 1998; 2001). The authors inhibited the heat-shock-induced apoptosis in Leishmania explain the stimulating IGF-I effect on leishmanian cells mexicana amazonensis (Charlab et al., 1990; Barcinski by a similarity of structure in receptors of leishmanian and et al., 1992; Welburn et al., 1996). Some mammalian mammalian cells. The receptor for IGF-I on L. mexicana cytokines (IL-3, IL-6, TNF, and IFN-G) are reported to promastigotes is a monomeric glycoprotein of a molecular induce in protozoan parasites a cellular reaction aimed at mass of 65 kDa and is antigenically related to the A-chain maintaining their viability (Olsson et al, 1992; Barcinski, of the human type 1 IGF-I receptor. Upon IGF-I stimulation Moreira, 1994; Csaba et al., 1995, Salotra et al., 1995; the receptor undergoes autophosphorylation at tyrosine Bakhiet et al., 1996). residues with activation of its signaling pathway. Activation Several works have demonstrated stimulation of of the IGF-I receptor also leads to phosphorylation of a proliferation of protozoa by EGF (Hide et al., 1989; 185-kDa molecule that is homologous to the substrate Sternberg, McGuigan, 1994; Selivanova et al., 2002; of the insulin receptor present in human cells, the insulin Shemarova et al., 2004). It was established that EGF receptor substrate 1 (IRS-1) (Gomes et al., 2001). produced a marked proliferative response in vivo in By the example of free-living ciliates Tetrahymena trypomastigotes of the Trypanosoma brucei strain Tc221 pyriformis and Tetrahymena thermophila, the vertebrate (Sternberg and McGuigan,
Recommended publications
  • Tyrosine Kinase – Role and Significance in Cancer
    Int. J. Med. Sci. 2004 1(2): 101-115 101 International Journal of Medical Sciences ISSN 1449-1907 www.medsci.org 2004 1(2):101-115 ©2004 Ivyspring International Publisher. All rights reserved Review Tyrosine kinase – Role and significance in Cancer Received: 2004.3.30 Accepted: 2004.5.15 Manash K. Paul and Anup K. Mukhopadhyay Published:2004.6.01 Department of Biotechnology, National Institute of Pharmaceutical Education and Research, Sector-67, S.A.S Nagar, Mohali, Punjab, India-160062 Abstract Tyrosine kinases are important mediators of the signaling cascade, determining key roles in diverse biological processes like growth, differentiation, metabolism and apoptosis in response to external and internal stimuli. Recent advances have implicated the role of tyrosine kinases in the pathophysiology of cancer. Though their activity is tightly regulated in normal cells, they may acquire transforming functions due to mutation(s), overexpression and autocrine paracrine stimulation, leading to malignancy. Constitutive oncogenic activation in cancer cells can be blocked by selective tyrosine kinase inhibitors and thus considered as a promising approach for innovative genome based therapeutics. The modes of oncogenic activation and the different approaches for tyrosine kinase inhibition, like small molecule inhibitors, monoclonal antibodies, heat shock proteins, immunoconjugates, antisense and peptide drugs are reviewed in light of the important molecules. As angiogenesis is a major event in cancer growth and proliferation, tyrosine kinase inhibitors as a target for anti-angiogenesis can be aptly applied as a new mode of cancer therapy. The review concludes with a discussion on the application of modern techniques and knowledge of the kinome as means to gear up the tyrosine kinase drug discovery process.
    [Show full text]
  • Identi®Cation and Role of Adenylyl Cyclase in Auxin Signalling in Higher
    letters to nature + + + P.P. thank the Academy of Finland and the Deutsche Forschungsgemeinschaft, respectively, for ®nancial CO , 53), 77 (C6H5 , 60), 73 (TMSi , 84); 6-methyl-4-hydroxy-2-pyrone: RRt 0.35, 198 (M+, 18), 183 ([M-Me]+, 16), 170 ([M-CO]+, 54), 155 ([M-CO-Me]+, support. + + Correspondence and requests for materials should be addressed to J.S. (e-mail: [email protected] 15), 139 ([M-Me-CO2] , 10), 127 ([M-Me-2CO] , 13), 99 (12), 84 (13), 73 + + freiburg.de). (TMSi , 100), 43 (CH3CO , 55). The numbers show m/z values, and the key fragments and their relative intensities are indicated in parentheses. Received 4 August; accepted 14 October 1998. erratum 1. Helariutta, Y. et al. Chalcone synthase-like genes active during corolla development are differentially expressed and encode enzymes with different catalytic properties in Gerbera hybrida (Asteraceae). Plant Mol. Biol. 28, 47±60 (1995). 2. Helariutta, Y. et al. Duplication and functional divergence in the chalcone synthase gene family of 8 Asteraceae: evolution with substrate change and catalytic simpli®cation. Proc. Natl Acad. Sci. USA 93, Crystal structure of the complex 9033±9038 (1996). 3. Thaisrivongs, S. et al. Structure-based design of HIV protease inhibitors: 5,6-dihydro-4-hydroxy-2- of the cyclin D-dependent pyrones as effective, nonpeptidic inhibitors. J. Med. Chem. 39, 4630±4642 (1996). 4. Hagen, S. E. et al. Synthesis of 5,6-dihydro-4-hydroxy-2-pyrones as HIV-1 protease inhibitors: the kinase Cdk6 bound to the profound effect of polarity on antiviral activity. J. Med. Chem.
    [Show full text]
  • Principles of Protein Phosphorylation Biophysical Chemistry 1, Fall 2010
    Principles of protein phosphorylation Biophysical Chemistry 1, Fall 2010 Signalling “cascades” Structural biology of phosphorylation Web assignment: http://pkr.genomics.purdue.edu Reversible protein phosphorylation Enzymatic reaction Posttranslational Control ΔG~12kcal/mol Kinases and phosphatases Phosphatase Kinase dephospho- phosphorylates rylates General Examples Signalling overview Cells are way too complex! MAPK/ERK Signaling Pathway RousExample:sarcoma virus Rous (RSV) sarcoma virus (RSV) gag - encodes capsid proteins pol - encodes reverse transcriptase env - encodes envelope proteins src - encodes a tyrosine kinase that attaches phosphate groups to the amino acid tyrosine in host cell proteins MutationsExample:, viruses Rous and cancer sarcoma virus (RSV) v-src lacks the C-terminal inhibitory phosphorylation site (tyrosine-527), and is therefore constitutively active as opposed to normal src (c-src) Continuous cell profileration tumor BiophysicsStructural of signalling Effect of Phosphorylation Phosphorylation is an important regulatory mechanism Can reversible attach/detach a phosphate and therefore switch “on”/”off” the function Effect of phosphorylation is manifold • Conformational change • Ordering/disordering • Electrostatic effects • Alternate binding behavior Signalling by reorientation Reorientation: A conformational switch Rmsd = 2.5Å DHP (red) and Z-Score = 4.6 DHPs74e (blue) (>3.6 same fold) Title: A phosphorylation-induced conformation change in dematin headpiece Author(s): Jiang ZHG, McKnight CJ Source: STRUCTURE Volume: 14 Issue: 2 Pages: 379-387 Published: FEB 2006 Order/disorderDisordering:transitions NtrC, a molecular switch upon phosphorylation Orange-yellow: unphosphorylated NtrC blue-cyan: phosphorylated NtrC Volkman et al., Science 2001, 291, 2429-33 Alternate Binding: SRC SH2 Src/SH2 interactions: binding vs release domain binding ExpectedCan conformationalwe understand effects (predict) the effect of phosphorylation Electrostatics Hydrogen bonding Size Mutational analysis Experimental data Lubman, O.Y.
    [Show full text]
  • Phosphorylation of Chicken Protein Tyrosine Phosphatase 1 by Casein Kinase II in Vitro
    EXPERIMENTAL and MOLECULAR MEDICINE, Vol. 29, No 4, 229-233, December 1997 Phosphorylation of chicken protein tyrosine phosphatase 1 by casein kinase II in vitro Eun Joo Jung,1 Kee Ryeon Kang1 and Introduction Yoon-Se Kang1,2 The phosphorylation of protein tyrosine residues is an early event in signal transduction initiated by binding of 1 Department of Biochemistry and Gyeongsang Institute of Cancer growth factors and hormones to their cognate receptors Research, College of Medicine, Gyeongsang National University, and it leads to regulation of cellular activities which include Chinju 660-280, Korea proliferation, differentiation, and also malignant transfor- 2 Corresponding author mation of cells (Hunter, 1989; Ullirich and Schlessinger, Accepted 17 November 1997 1990; Cantley et al., 1991). Under normal conditions, the level of tyrosine phosphorylation within a cell is determined by a balance between the actions of protein tyrosine Abbreviations: CPTP, chicken protein tyrosine phosphatase; HPTP1B, human placenta kinases (PTKs) and protein tyrosine phosphatases (PTPs) protein tyrosine phosphatase 1B; CKII, casein kinase II; MAP kinase, mitogen-activated (Hunter, 1989; Fischer et al., 1991; Trowbridge, 1991). protein kinase; GST, glutathione S-transferase; pNPP, p-nitrophenyl phosphate; EGF, PTPs do not simply reverse the action of tyrosine kinases, epidermal growth factor but rather, PTP itself may play a central role in cellular regulation. PTPs are generally classified as transmem- brane (receptor-type) and nontransmembrane (nonrecep- tor-type) enzymes based on the presence or absence of extracellular and transmembrane portions of their predicted sequence (Fischer et al., 1991). Because the activity of Abstract tyrosine kinase can be controlled by phosphorylation, it has been postulated that PTP activity may be regulated The phosphorylation and dephosphorylation of by phosphorylation as well.
    [Show full text]
  • Mechanism of Insulin Receptor Kinase Inhibition in Non-Insulin- Dependent Diabetes Mellitus Patients
    Mechanism of insulin receptor kinase inhibition in non-insulin- dependent diabetes mellitus patients. Phosphorylation of serine 1327 or threonine 1348 is unaltered. M Kellerer, … , K Siddle, H U Häring J Clin Invest. 1995;96(1):6-11. https://doi.org/10.1172/JCI118073. Research Article The tyrosine kinase activity of insulin receptor isolated from the skeletal muscle of NIDDM patients has previously been found to be decreased compared with the activity of receptor from nondiabetic subjects but the mechanism underlying this defect is unknown. Phosphorylation of receptor serine/threonine residues has been proposed to exert an inhibitory influence on receptor tyrosine kinase activity and Ser 1327 and Thr 1348 have been identified as specific sites of phosphorylation in the insulin receptor COOH terminal domain. To address the potential negative regulatory role of phosphorylation of these residues in vivo, we assessed the extent of phosphorylation of each site in insulin receptor isolated from the skeletal muscle of 12 NIDDM patients and 13 nondiabetic, control subjects. Phosphorylation of Ser 1327 and Thr 1348 was determined using antibodies that specifically recognize insulin receptor phosphorylated at these sites. In addition, a phosphotyrosine-specific antibody was used to monitor receptor tyrosine phosphorylation. The extent of insulin-induced tyrosine autophosphorylation was decreased in receptor isolated from diabetic versus nondiabetic muscle, thus confirming earlier reports. In contrast, there was no significant difference in the extent of phosphorylation of either Ser 1327 or Thr 1348 in receptor isolated from diabetic or nondiabetic muscle as assessed by immunoprecipitation (Ser 1327: 5.6 +/- 1.6% diabetics vs. 4.7 +/- 2.0% control; Thr 1348: 3.8 +/- 1.0% diabetics vs.
    [Show full text]
  • Mom Identifies a Receptor for the Drosophila JAK/STAT Signal Transduction Pathway and Encodes a Protein Distantly Related to the Mammalian Cytokine Receptor Family
    Downloaded from genesdev.cshlp.org on October 1, 2021 - Published by Cold Spring Harbor Laboratory Press mom identifies a receptor for the Drosophila JAK/STAT signal transduction pathway and encodes a protein distantly related to the mammalian cytokine receptor family Hua-Wei Chen,1,3 Xiu Chen,1,3 Su-Wan Oh,1 Maria J. Marinissen,2 J. Silvio Gutkind,2 and Steven X. Hou1,4 1The Laboratory of Immunobiology, National Institutes of Health, National Cancer Institute at Frederick, Frederick, Maryland 21702, USA; 2Oral and Pharyngeal Cancer Branch, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, Maryland 20892, USA The JAK/STAT signal transduction pathway controls numerous events in Drosophila melanogaster development. Receptors for the pathway have yet to be identified. Here we have identified a Drosophila gene that shows embryonic mutant phenotypes identical to those in the hopscotch (hop)/JAK kinase and marelle (mrl)/Stat92e mutations. We named this gene master of marelle (mom). Genetic analyses place mom’s function between upd (the ligand) and hop. We further show that cultured cells transfected with the mom gene bind UPD and activate the HOP/STAT92E signal transduction pathway. mom encodes a protein distantly related to the mammalian cytokine receptor family. These data show that mom functions as a receptor of the Drosophila JAK/STAT signal transduction pathway. [Key Words: Drosophila; JAK/STAT; signal transduction; cytokine receptor] Received October 19, 2001; revised version accepted December 6, 2001. The JAK/STAT signal transduction pathway was identi- (upd) secreted glycoprotein identifies an in vivo ligand fied through studies of the transcriptional activation re- activating the HOP/STAT92E pathway (Harrison et al.
    [Show full text]
  • Protein Kinases Phosphorylation/Dephosphorylation Protein Phosphorylation Is One of the Most Important Mechanisms of Cellular Re
    Protein Kinases Phosphorylation/dephosphorylation Protein phosphorylation is one of the most important mechanisms of cellular responses to growth, stress metabolic and hormonal environmental changes. Most mammalian protein kinases have highly a homologous 30 to 32 kDa catalytic domain. • Most common method of reversible modification - activation and localization • Up to 1/3 of cellular proteins can be phosphorylated • Leads to a very fast response to cellular stress, hormonal changes, learning processes, transcription regulation .... • Different than allosteric or Michealis Menten regulation Protein Kinome To date – 518 human kinases known • 50 kinase families between yeast, invertebrate and mammaliane kinomes • 518 human PKs, most (478) belong to single super family whose catalytic domain are homologous. • Kinase dendrogram displays relative similarities based on catalytic domains. • AGC (PKA, PKG, PKC) • CAMK (Casein kinase 1) • CMGC (CDC, MAPK, GSK3, CLK) • STE (Sterile 7, 11 & 20 kinases) • TK (Tryosine kinases memb and cyto) • TKL (Tyrosine kinase-like) • Phosphorylation stabilized thermodynamically - only half available energy used in adding phosphoryl to protein - change in free energy forces phosphorylation reaction in one direction • Phosphatases reverse direction • The rate of reaction of most phosphatases are 1000 times faster • Phosphorylation occurs on Ser/The or Tyr • What differences occur due to the addition of a phosphoryl group? • Regulation of protein phosphorylation varies depending on protein - some turned on or off
    [Show full text]
  • G Protein-Coupled Receptors
    G PROTEIN-COUPLED RECEPTORS Overview:- The completion of the Human Genome Project allowed the identification of a large family of proteins with a common motif of seven groups of 20-24 hydrophobic amino acids arranged as α-helices. Approximately 800 of these seven transmembrane (7TM) receptors have been identified of which over 300 are non-olfactory receptors (see Frederikson et al., 2003; Lagerstrom and Schioth, 2008). Subdivision on the basis of sequence homology allows the definition of rhodopsin, secretin, adhesion, glutamate and Frizzled receptor families. NC-IUPHAR recognizes Classes A, B, and C, which equate to the rhodopsin, secretin, and glutamate receptor families. The nomenclature of 7TM receptors is commonly used interchangeably with G protein-coupled receptors (GPCR), although the former nomenclature recognises signalling of 7TM receptors through pathways not involving G proteins. For example, adiponectin and membrane progestin receptors have some sequence homology to 7TM receptors but signal independently of G-proteins and appear to reside in membranes in an inverted fashion compared to conventional GPCR. Additionally, the NPR-C natriuretic peptide receptor has a single transmembrane domain structure, but appears to couple to G proteins to generate cellular responses. The 300+ non-olfactory GPCR are the targets for the majority of drugs in clinical usage (Overington et al., 2006), although only a minority of these receptors are exploited therapeutically. Signalling through GPCR is enacted by the activation of heterotrimeric GTP-binding proteins (G proteins), made up of α, β and γ subunits, where the α and βγ subunits are responsible for signalling. The α subunit (tabulated below) allows definition of one series of signalling cascades and allows grouping of GPCRs to suggest common cellular, tissue and behavioural responses.
    [Show full text]
  • Phosphorylation of Protein 4.1 on Tyrosine-418 Modulates Its Function
    Proc. Nati. Acad. Sci. USA Vol. 88, pp. 5222-5226, June 1991 Biochemistry Phosphorylation of protein 4.1 on tyrosine-418 modulates its function in vitro (epidermal growth factor receptor/spectrin/actin assembly) GOSUKONDA SUBRAHMANYAM*, PAUL J. BERTICStt, AND RICHARD A. ANDERSON**§ Department of *Pharmacology and tPhysiological Chemistry, and the tCell and Molecular Biology Program, University of Wisconsin Medical School, 1300 University Avenue, Madison, WI 53706 Communicated by Vincent T. Marchesi, March IS, 1991 ABSTRACT Protein 4.1 was initially characterized as a actin/protein 4.1 complex (12). However, phosphorylation of protein that regulates cytoskeletal assembly in erythrocytes. protein 4.1 by protein kinase C also reduces protein 4.1 However, recent studies have shown that protein 4.1 is ubiq- binding to band 3 but not to glycophorin, while phosphory- uitous in mammalian cells. Here, we show that protein 4.1 is lation by cAMP-dependent kinase does not affect membrane phosphorylated on tyrosine by the epidermal growth factor interactions (12). These results suggest that protein 4.1 is receptor (EGFR) tyrosine kinase. The phosphorylation site has phosphorylated at multiple sites by different protein kinases, been localized to the 8-kDa domain, which has one tyrosine, and each phosphorylation event selectively modulates pro- tyrosine-418. The 8-kDa region is required for the assembly of tein 4.1 function. The phosphorylation sites by cAMP- the spectrin/actin complex, and phosphorylation by EGFR dependent protein kinase and protein kinase C are in the reduced the ability ofprotein 4.1 to promote the assembly ofthe 8-kDa and 16-kDa domains (10).
    [Show full text]
  • Β-Catenin Signaling Dynamics Regulate Cell Fate in Differentiating Neural Stem Cells
    β-Catenin signaling dynamics regulate cell fate in differentiating neural stem cells Alyssa B. Rosenblooma, Marcin Tarczynski a, Nora Lama, Ravi S. Kaneb,1, Lukasz J. Bugaja,c,1, and David V. Schaffera,d,e,f,1 aDepartment of Bioengineering, University of California, Berkeley, CA 94720; bSchool of Chemical & Biomolecular Engineering, Georgia Institute of Technology, Atlanta, GA 30332; cDepartment of Bioengineering, University of Pennsylvania, Philadelphia, PA 19104; dDepartment of Chemical and Biomolecular Engineering, University of California, Berkeley, CA 94720; eDepartment of Molecular and Cell Biology, University of California, Berkeley, CA 94720; and fHelen Wills Neuroscience Institute, University of California, Berkeley, CA 94720 Edited by Randall T. Moon, University of Washington, Seattle, WA, and approved September 21, 2020 (received for review May 4, 2020) Stem cells undergo differentiation in complex and dynamic environ- of how signaling dynamics impact cellular function. Optogenetics ments wherein instructive signals fluctuate on various timescales. has recently emerged as a field in which light—which can readily Thus, cells must be equipped to properly respond to the timing of be varied in intensity, space, and time—is harnessed to precisely signals, for example, to distinguish sustained signaling from transient modulate cell-signaling pathways. In this approach, light-sensitive noise. However, how stem cells respond to dynamic variations in proteins are engineered to interface with specific signaling path- differentiation cues is not well characterized. Here, we use optoge- ways, and the subsequent introduction of such an optogenetic netic activation of β-catenin signaling to probe the dynamic responses construct into cells renders the signaling pathway responsive to of differentiating adult neural stem cells (NSCs).
    [Show full text]
  • Structural Basis of O-Glcnac Recognition by Mammalian 14-3-3 Proteins
    Structural basis of O-GlcNAc recognition by mammalian 14-3-3 proteins Clifford A. Tolemana,1, Maria A. Schumachera,1, Seok-Ho Yub, Wenjie Zenga, Nathan J. Coxa, Timothy J. Smitha, Erik J. Soderblomc, Amberlyn M. Wandsb, Jennifer J. Kohlerb, and Michael Boycea,2 aDepartment of Biochemistry, Duke University School of Medicine, Durham, NC 27710; bDepartment of Biochemistry, University of Texas Southwestern Medical Center, Dallas, TX 75390; and cDuke Proteomics and Metabolomics Core Facility, Center for Genomic and Computational Biology, Duke University, Durham, NC 27710 Edited by Carolyn R. Bertozzi, Stanford University, Stanford, CA, and approved April 23, 2018 (received for review December 24, 2017) O-GlcNAc is an intracellular posttranslational modification that gov- Results erns myriad cell biological processes and is dysregulated in human We developed a biochemical approach to test the hypothesis that diseases. Despite this broad pathophysiological significance, the O-GlcNAc is specifically recognized by mammalian reader pro- biochemical effects of most O-GlcNAcylation events remain unchar- teins. First, we derived a consensus O-GlcNAcylated peptide acterized. One prevalent hypothesis is that O-GlcNAc moieties may sequence by aligning 802 mapped Ser-O-GlcNAc sites (34–36) be recognized by “reader” proteins to effect downstream signaling. (Fig. 1A)(www.phosphosite.org). We noted that a Pro-Val-Ser However, no general O-GlcNAc readers have been identified, leav- tripeptide observed previously in smaller datasets (37, 38) also ing a considerable gap in the field. To elucidate O-GlcNAc signaling emerged in our sequence, suggesting that this motif may be mechanisms, we devised a biochemical screen for candidate O-GlcNAc important for O-GlcNAc modification and/or recognition.
    [Show full text]
  • AMP-Activated Protein Kinase: the Current Landscape for Drug Development
    REVIEWS AMP-activated protein kinase: the current landscape for drug development Gregory R. Steinberg 1* and David Carling2 Abstract | Since the discovery of AMP-activated protein kinase (AMPK) as a central regulator of energy homeostasis, many exciting insights into its structure, regulation and physiological roles have been revealed. While exercise, caloric restriction, metformin and many natural products increase AMPK activity and exert a multitude of health benefits, developing direct activators of AMPK to elicit beneficial effects has been challenging. However, in recent years, direct AMPK activators have been identified and tested in preclinical models, and a small number have entered clinical trials. Despite these advances, which disease(s) represent the best indications for therapeutic AMPK activation and the long-term safety of such approaches remain to be established. Cardiovascular disease Dramatic improvements in health care coupled with identifying a unifying mechanism that could link these (CVD). A term encompassing an increased standard of living, including better nutri- changes to multiple branches of metabolism followed diseases affecting the heart tion and education, have led to a remarkable increase in the discovery that the AMP-activated protein kinase or circulatory system. human lifespan1. Importantly, the number of years spent (AMPK) provided a common regulatory mechanism in good health is also increasing2. Despite these positive for inhibiting both cholesterol (through phosphoryla- Non-alcoholic fatty liver disease developments, there are substantial risks that challenge tion of HMG-CoA reductase (HMGR)) and fatty acid (NAFLD). A very common continued improvements in human health. Perhaps the (through phosphorylation of acetyl-CoA carboxylase disease in humans in which greatest threat to future health is a chronic energy imbal- (ACC)) synthesis8 (BOx 1).
    [Show full text]